Myricanol modulates skeletal muscle-adipose tissue crosstalk to alleviate high-fat diet-induced obesity and insulin resistance.

Shengnan ShenQiwen LiaoTian ZhangRuile PanLi-Gen Lin

Published in: British journal of pharmacology (2019)

Myricanol modulates skeletal muscle-adipose tissue crosstalk, to stimulate browning of adipose tissue and improve insulin sensitivity in skeletal muscle. Myricanol might be a potential candidate for treating insulin resistance and obesity.

Keyphrases

insulin resistance
high fat diet induced
adipose tissue
skeletal muscle
high fat diet
polycystic ovary syndrome
metabolic syndrome
type diabetes
glycemic control
risk assessment
body mass index
human health
weight gain